Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Max, Kappenstein"'
Autor:
Nadia Ninosu, Suna Hoelker, Max Kappenstein, Sylvia Buettner, Wiebke K. Peitsch, Marthe-Lisa Schaarschmidt
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background Topical medication is the mainstay for treatment of mild psoriasis. However, dissatisfaction with topicals is common and rates of non-adherence are high. Assessing patients’ perspectives can help to identify unmet needs. Objective Our ai
Externí odkaz:
https://doaj.org/article/6c4ac45bd451403da08b3644597e52a1
Autor:
Philip Keye, Anne Charlet, Michael Reth, Kathrin Kläsener, Max Kappenstein, Cornelia Endres, Teresa Poggio, Nikolas von Bubnoff, Anna Lena Illert, Jana Sänger, Stefanie Kreutmair, Cornelius Miething, Christoph Rummelt, Justus Duyster, Sivahari P. Gorantla
Publikováno v:
Leukemia. 36:701-711
FLT3-ITD is the most predominant mutation in AML being expressed in about one-third of AML patients and is associated with a poor prognosis. Efforts to better understand FLT3-ITD downstream signaling to possibly improve therapy response are needed. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fb8aa8e0d51349749e9a105ed9eb4bc
https://doi.org/10.1038/s41375-021-01462-4
https://doi.org/10.1038/s41375-021-01462-4
Autor:
Anne, Charlet, Max, Kappenstein, Philip, Keye, Kathrin, Kläsener, Cornelia, Endres, Teresa, Poggio, Sivahari P, Gorantla, Stefanie, Kreutmair, Jana, Sänger, Anna L, Illert, Cornelius, Miething, Michael, Reth, Justus, Duyster, Christoph, Rummelt, Nikolas, von Bubnoff
Publikováno v:
Leukemia. 36(3)
FLT3-ITD is the most predominant mutation in AML being expressed in about one-third of AML patients and is associated with a poor prognosis. Efforts to better understand FLT3-ITD downstream signaling to possibly improve therapy response are needed. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc07ab8d92a1337b286a0127b5c886f7
https://pubmed.ncbi.nlm.nih.gov/34750506
https://pubmed.ncbi.nlm.nih.gov/34750506